The present study evaluated scoring systems for ruptured abdominal aortic aneurysms treated by open surgery. The Edinburgh Rupture Aneurysm Score was superior in predicting outcome and handling. A stepwise increase in the score was correlated with a consecutive increase in mortality. Moreover, the analyses showed a diverse prevalence of survival between different subgroups (10e70%). This high variance underscores the need for risk stratification in clinical trials because only risk based subgroups allow precise analysis in different clinical settings and for different treatment options.
INTRODUCTION
Endovascular aneurysm repair (EVAR) and open surgical repair (OSR) are competitively employed for the treatment of ruptured aortic abdominal aneurysms (rAAA), with continued debate about the best treatment option with the lowest mortality rate. Systematic reviews based on observational studies have revealed survival benefits for EVAR, 1e3 although randomized trials did not show significant differences in mortality. 4e6 The reason for those disparate results is unclear.
High mortality variance between different clinical trials illustrates one dilemma: 7 RAAA are not classified. Patients with retroperitoneal bleeding are compared with patients with "free ruptures," and patients under resuscitation are compared with hemodynamically stable patients. Clearly, intra-abdominal bleeding is the overall life limiting factor causing instability and hemodynamic shock. One way to assess the severity of the patient's condition and hemodynamic shock is the use of risk scores, which were initially introduced to vascular surgery to predict outcome. The Vascular Study Group of New England (VSGNE) rAAA risk score is derived from intra-operative and pre-operative parameters. 8 The Edinburgh Rupture Aneurysm Score (ERAS), 9 the Glasgow Aneurysm Score (GAS), 10 and the Hardman Index 11 are derived exclusively from pre-operative parameters (Table 1) .
Besides predicting mortality, scoring models can be useful in the design of clinical trials. Scores can be applied to stratify cohorts according to their severity of rupture, and, hence, low risk patients and high risk patients can be pooled and analyzed separately. 12 This is of special interest as clinical trials are conducted in a manner to avoid heterogeneous patient characteristics. In addition, opposing results from recent clinical trials could be clarified by risk stratification as this has often been neglected. 7 In the present study, several scoring systems were tested in patients with rAAA treated by OSR. The VSGNE risk score and ERAS were validated for the first time in a European population by a research group who did not develop the score. In addition, the GAS and Hardman Index were tested. The present report underscores the diverse prevalence of survival rates between subgroups and emphasizes the use of scoring models when comparing EVAR and OSR.
METHODS

Setting
This retrospective study was conducted at the Division for Vascular Surgery, Department of Surgery, University Hospital Leipzig (Leipzig, Germany) and comprised only patients who underwent OSR. Ninety-eight patients with rAAA were admitted between January 2002 and August 2013, and 92 of them underwent OSR. Six patients were excluded from analysis because they were treated by EVAR; this was first used in the department in 2011 and performed when suitable (proximal neck length > 10 mm, proximal neck diameter < 32 mm and proximal neck angulation < 90 ).
Pre-operative diagnostic steps were supervised by the consultant vascular surgeon including medical history, physical examination, abdominal ultrasound, and computed tomography. Surgery was performed by the consultant vascular surgeon. The diagnosis of rAAA was defined as a considerable amount of retroperitoneal or intraperitoneal blood when no other cause of bleeding was identified. The intensive care unit provided beds exclusively for surgical patients and was supervised by the Department of Anesthesiology and Intensive Care Medicine. 13 Medical records were reviewed based on outcome and clinical characteristics including lowest systolic blood pressure before surgery (SBP), time between admission and surgery, aortic clamp position, blood transfusion, type of rupture, and type of surgery.
Scoring models
To predict the outcome in patients who underwent OSR, different scoring models were assessed and validated ( Table 1) . The following models were tested: the VSGNE rAAA risk score, 8 ERAS, 9 GAS, 10 and the Hardman Index.
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These models are based on pre-operative patient characteristics, except for the VSGNE risk score (which includes suprarenal clamping as an intra-operative variable). The GAS represents a parametric variable. Therefore, the score was split into quartiles (1e4), allowing comparison of GAS with other scores that have categorical characteristics. Scores for ERAS, VSGNE, GAS, and the Hardman Index were not calculated in 6, 5, 2, and 18 cases, respectively (Fig. S1 , Supplementary material). Missing parametric variables were imputed by linear regression; missing categorical values were imputed by logistic regression.
Statistical analyses
The area under the receiver operating characteristic curve (AUC) was calculated to assess the discriminative power of each scoring model to predict whether a patient would survive or die. Calibration was assessed by HosmereLemeshow test c 2 to determine the goodness of fit. Briefly, a c 2 > 0.05 indicated a good fit as the observed mortality does not differ from the predicted mortality according to the grade of the score. Univariate analysis of all variables was carried out to RAAA scoring system Edinburgh Ruptured Aneurysm Score ¼1 (for hemoglobin <9 g/dL) þ 1 (for GCS < 15) þ 1 (for pre-operative systolic BP < 90 mmHg) VSGNE rAAA risk score ¼2 (for age > 76) þ 2 (for cardiac arrest) þ 1 (for loss of consciousness) þ 1 (for suprarenal clamping) Glasgow Aneurysm Score ¼Age þ 17 (for shock) þ 7 (for myocardial disease) þ 10 (for cerebrovascular disease) þ 14 (for renal disease) Hardman Index
BP ¼ blood pressure; GCS ¼ Glasgow Coma Scale; VSGNE ¼ Vascular Study Group of New England. Each patient was calculated and staged selectively. Myocardial disease is defined as previous myocardial infarction and/or ongoing angina. Cerebrovascular disease is classified as all grades of stroke, including transient ischemic attack. Renal disease is classified as acute or chronic renal failure. Shock is defined as hypotension, sweating, tachycardia, and pallor.
assess the correlation with in hospital mortality. To enter parametric variables into the univariate analysis, the Youden index was calculated and used as a threshold to categorize variables. A multivariate model was created by logistic regression to determine the simultaneous and independent effects of significant variables associated with in hospital mortality. Therefore, a standard variable selection was made by an automatic stepwise procedure using a forwardebackward method. Variables with p < .10 were entered into the multivariate analysis. Continuous variables are presented as the median, whereas categorical variables are given as percentages. If suitable, the interquartile range (IQR) and 95% confidence interval (CI) are specified. A value of p < .05 was considered significant. Statistical analyses were carried out using SPSS v 20 (SPSS, Chicago, IL, USA).
RESULTS
Overall in hospital mortality and one year mortality were 38% (n ¼ 35) and 44.6% (n ¼ 41), respectively. Baseline characteristics are listed in Table 2 and intra-operative characteristics in Table 3 . Cumulative survival rates are shown in Fig. 1 and calibration of the scores are listed in Table S1 (Supplementary material). The median age of the study cohort was 74 years (IQR; 67.3e80.4). The main procedure was aorto-aortic repair (64.1%), followed by aorto-bi-iliac (20.7%) and aorto-bi-femoral repair (3.3%; Table 4 ). Fifty patients were admitted initially to the emergency department and 42 patients were transferred from an external institution.
ERAS
The ERAS derived from three pre-operative variables (Table 1) . A stepwise increase in ERAS was linked to a consecutive increase in mortality (Fig. 1A) . The mortality of ERAS 1 was 27.3% and ERAS ¼ 3 was 68.8%. The AUC was 0.71 (95% CI 0.6e0.82; p ¼ .001; Table 4 ; Fig. S2A , Supplementary material). Most patients (n ¼ 55) were assigned to ERAS 1. On univariate analysis, GCS <15 (OR 3.7; 95% CI 1.5e9.2; p ¼ .005) and a pre-operative SBP <90 mmHg (OR 5.1; 95% CI 2.1e12.8; p < .001) were significant predictors of in hospital mortality. The accuracy of calibration was the best of all tested scores (Table 1) .
VSGNE rAAA risk score
The VSGNE rAAA risk score was calculated from three preoperative and one intra-operative parameter (Table 1) . A stepwise increase in the score correlated with an increase in hospital mortality (Fig. 1B) except for a score 4. Fewer patients (n ¼ 9) were assigned to a score 4, but there were equal numbers of patients assigned to stages 1e3. VSGN rAAA risk scores of 0 or 3 showed in hospital mortality of 10.5% and 72%, respectively. The AUC was the highest of all tested scores (AUC ¼ 0.76; 95% CI 0.66e0.87; p < .001; Table 4 ; Fig. S2B, Supplementary material) , while the calibration was low (c 2 ¼ 6.9; p ¼ .08). Age >76 years (OR 3.5; 95% CI 1.4e8.5; p ¼ .006), pre-operative cardiac arrest (OR 4.2; 95% CI 1.3e13.5; p ¼ .017), and loss of consciousness (OR 3.4; 95% CI 1.4e8.4; p ¼ .007) were associated with higher OR.
GAS
The GAS derives exclusively from pre-operative characteristics. An increase in the GAS was associated with an increase in mortality (Fig. 1C) . Patient distribution was equal because of division into quartiles and the model did not have any lack of fit (Table 4 ). A GAS ¼ 1 was associated with a mortality of 9.1% and a GAS ¼ 4 with a mortality of 68.2%. The AUC was 0.75 (95% CI 0.64e0.85; p < .001; Table 4 ; Fig. S2C , Supplementary material), the second highest value of all evaluated scores. The univariate analysis revealed hemodynamic shock (OR 4.1; 95% CI 1.6e10.5; p ¼ .004) and age >76 years (OR 3.5; 95% CI 1.4e8.5; p ¼ .006) to be significant predicting variables for in hospital mortality.
Hardman Index
A consecutive increase was observed with a stepwise increase in the Hardman Index (Fig. 1D) . A Hardman Index ¼ 1 was associated with an in hospital mortality of 7.7%, and a Hardman Index 3 with a mortality of 53.8%. The AUC was the lowest of all scores with a value of 0.68 (95% CI 0.56e 0.80; p < .011; Table 4 ; Fig. S2D ). In addition, the Hardman Index demonstrated lack of fit (Table 4) . On univariate analysis, age >76 years (OR 3.5; 95% CI 1.4e8.5; p ¼ .006), loss of consciousness (OR 3.4; 95% CI 1.4e8.4; p ¼ .007), and electrocardiographic ischemia (OR 3.1; 95% CI 1.0e9.6; p ¼ .049) were predictive factors for in hospital mortality.
According to univariate analysis, all parameters with p < .10 were entered into a multivariate model. Free blood in the abdomen (OR 7.6; 95% CI 1.5e39.6; p ¼ .02) and GCS <15 correlated with in hospital mortality (OR 3.0; 95% CI 1.1e8.3; p ¼ .03). The discrimination and calibration of the scoring models were similar when comparing raw and imputed data (Tables S2 and S3 , Supplementary material).
DISCUSSION
The VGNSE rAAA risk score and ERAS were introduced as scoring models to vascular surgery. Here, for the first time, Figure 1 . Cumulative mortality rates. The in hospital mortality of ERAS, VSGNE rAAA risk score, GAS, and Hardman Index are plotted against increasing score. both scores were validated in a European population by a research group who did not design the score. In addition, the GAS and Hardman Index were tested. Strikingly, ERAS was superior in predicting outcome and was easy to use. A stepwise increase in the score was correlated with a consecutive increase in mortality demonstrating the best calibration of all tested scores (c 2 ¼ 0.44; p ¼ .81). The VSGNE rAAA risk score showed the highest discrimination in comparison with ERAS, GAS, and the Hardman Index. However, this score failed to identify patients with the highest risk of mortality because of low calibration. A score ¼ 3 was associated with a mortality of 72%, but a score4 with a mortality of 55.6%. The reason for this deviation might be the underpowered number of patients. Only nine patients had a score of 4 points. The mortality rates (VSGNE rAAA risk score ¼ 0; 1; 2; 3) were in line with those in the initial publication. 8 Interestingly, a recent analysis applied the VSGNE rAAA risk score in patients with rAAA either treated with EVAR (n ¼ 514) or OSR (n ¼ 651) 12 (note, the study was published by the research group who designed the score). Interestingly, they revealed lower mortality and morbidity for low risk (score: 0e1) and medium risk patients (score: 2e3) when treated with EVAR. In contrast, patients at high risk showed no differences in survival between treatments.
The GAS score demonstrated good discriminatory power. A stepwise increase in the score was associated with increases in mortality. Moreover, the model did not demonstrate any lack of fit (Table 4 ). The GAS has a parametric scale, which differed from that of the other scores tested. To classify patients according to their risk (e.g. compare low risk patients treated by EVAR with low risk patients treated by OSR), pooling of data is necessary. Therefore, the GAS was compiled into quartiles, as done previously in the same manner by different research groups. 9, 8, 14, 15 The GAS had already been validated in patients who underwent EVAR. 16, 17 However, in particular, handling and calculation of this score seems to be impractical. Medical history including myocardial, renal, and cerebrovascular disease is compulsory, and assessment can be impossible in unconscious patients.
It is noted that ERAS is derived exclusively of hemodynamic shock parameters (Table 1) . Universal application of EVAR and OSR is feasible without any modification. The mortality for ERAS 1, 2, and 3 was 27%, 47%, and 69%, respectively. This is in accordance with the initial publication and prospective validation of Tambyraja and colleagues. 9, 18 ERAS demonstrated the best calibration of all tested scores and a high AUC. On univariate logistic regression of single parameters of the validated scores, not all of them were significant (Table 5) . Interestingly, the strongest predictor for survival was free blood assessed and reported by the surgeon. Hence, to improve the performance of ERAS, free blood was added into the model, scored with 1 point. The AUC increased (Fig. S3, Supplementary material ) and the modified score showed an excellent goodness of fit (c 2 ¼ 0.04; p ¼ .98, Table S1 , Supplementary material). Unfortunately, free blood was assessed during surgery and might be not assessable for EVAR. Therefore, further studies are needed to test whether this parameter can be determined by imaging methods and is affected by the trauma of the laparotomy.
The performance of the Hardman Index was inferior in the present analysis. The AUC was lowest for this score (AUC 0.68; 95% CI 0.56e0.80) and high risk patients could not be identified accurately. A patient with a score ¼ 2 had an in hospital mortality of 50%, whereas a score 3 had a mortality of 54%. GAS for EVAR has been validated; 19e21 however, studies have revealed a lower discriminatory power of this score in comparison with ERAS and VSGNE risk score. 8, 18 In particular, assessment of ischemia based on electrocardiography might be cumbersome in an emergency situation.
The present study had limitations. The study design was retrospective and the rate of missing values was <3% (Fig. S1, Supplementary material) . Moreover, the time period of the study (>10 years) and the limited study cohort restrict the degree to which the results can be generalized. In addition, the performed statistical tests were impacted by the low events per variable (EPV). A EPV10 is considered to be sufficient for bias, precision, and significance when used in a multivariate model. 22 Likewise, only parameters that were tested in the univariate analysis were entered into the multivariate analysis (n > 10; p < 0.10). The scoring models had been calculated exclusively in patients who underwent OSR; however, if used for risk stratification, the scores should be applicable and validated for both EVAR and OSR. Likewise, the proposed scoring systems are barely validated for EVAR in rAAA. In particular, ERAS has not been evaluated at all, with GAS tested in two studies, 16, 17 which gave AUC (0.69 and 0.88) comparable with the present results (AUC0.75; 95% CI 0.64e0.85). Furthermore, the Hardman Index was validated in patients treated by EVAR, and showed a significant correlation with mortality.
19e21
The common use of scoring models is to predict mortality, but, interestingly, in the era of EVAR, scoring models can be used for different purposes. This was demonstrated strikingly in a recent clinical trial comparing patients with different VSGNE risk scores either treated with EVAR or OSR. 12 However, multiple studies including the randomized .4 (1.4e8.4) .007 Electrocardiographic ischemia 18.3% (15) 3.1 (1.0e9.6) .049
The variables derived from ERAS, VSGNE rAAA risk score, GAS, Hardman index, and peri-operative characteristics. Only variables with p < .05 are shown. trials 4e6 have been published comparing EVAR and OSR without performing a consecutive risk stratification. Consequently, mortality rates for EVAR and OSR between clinical trials ranged from 5%e53% and 15%e53%, respectively. 7 The reason for those disparate results remains unclear, while particular predictors are known to affect the outcome for both EVAR and OSR. 8, 20, 23, 18 Applying scoring models to the study design might allow for dissection of the wide range of mortality, and selection of patients with survival benefits in regards to the treatment. Score assessment can be done easily in the emergency department as only a few parameters are required (Table 1) . Note, the application of scoring models for elective AAA repair might be possible to perform risk stratification and analyze patients according to their risk. 24 
CONCLUSION
In this study, different scoring models were tested in rAAAs treated by OSR. ERAS was superior, with the best calibration of all tested scores and demonstrating striking ease of use. A stepwise increase in the score was correlated with a consecutive increase in mortality rate. The applicability of the proposed scoring models is given for OSR but remains uncertain for EVAR. Hence, future clinical trials are needed to test those scores. A detailed risk stratification could allow precise comparison between EVAR and OSR as this approach is novel for rAAA, having been neglected in the past. 
